TY  - GEN
AU  - McEvoy,John W
AU  - Ibrahim,Khalil
AU  - Kickler,Thomas S
AU  - Clarke,William A
AU  - Hasan,Rani K
AU  - Czarny,Matthew J
AU  - Keramati,Ali R
AU  - Goli,Rakesh R
AU  - Gratton,Travis P
AU  - Brinker,Jeffrey A
AU  - Chacko,Matthews
AU  - Hwang,Chao-Wei
AU  - Johnston,Peter V
AU  - Miller,Julie M
AU  - Trost,Jeffrey C
AU  - Herzog,William R
AU  - Blumenthal,Roger S
AU  - Thiemann,David R
AU  - Resar,Jon R
AU  - Schulman,Steven P
TI  - Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With Ticagrelor Inhibition and Fentanyl)
SN  - 1524-4539
PY  - 2019///0409
KW  - Administration, Intravenous
KW  - Administration, Oral
KW  - Analgesics, Opioid
KW  - administration & dosage
KW  - Baltimore
KW  - Blood Platelets
KW  - drug effects
KW  - Drug Interactions
KW  - Drug Monitoring
KW  - methods
KW  - Female
KW  - Fentanyl
KW  - Gastrointestinal Absorption
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Platelet Aggregation
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Purinergic P2Y Receptor Antagonists
KW  - Receptors, Purinergic P2Y12
KW  - blood
KW  - Risk Assessment
KW  - Ticagrelor
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1161/CIRCULATIONAHA.117.031678
ER  -